Back to Directory

Rulan Griesel

Email

rulan.x.griesel@viivhealthcare.com

Phone

44 (0)744 2775996

Institution

ViiV Healthcare

Address

GSK
79 New Oxford Street
London, WC1A 1DG
UK

Request an Update

Affiliated Studies

IMPAACT 2036: Phase I/II Study of the Safety, Tolerability, Acceptability, and Pharmacokinetics of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children Living with HIV-1, Two to Less Than 12 Years of Age

DAIDS Number

Research Area

Study Status

IMPAACT 2023: A Phase I Study of the Safety, Tolerability, and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1

DAIDS Number

Research Area

Study Status

Closed to Accrual